SERPINE1 and esophageal squamous cell carcinoma: Herein, for the first time, we showed that anti-PAI-1 mAbs inhibit ESCC motility in an LRP1-dependent manner, and mAb-2E3 blocks the binding of PAI-1 and LRP1-Cluster II domain.